CIAM
SBFM

Caitong International Asset Management’s Sunshine Biopharma SBFM Stock Holding History

Caitong International Asset Management’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$6 ﹤0.01% 2833

Other funds holding SBFM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SFG
Strive Financial Group Carmel, Indiana $230M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Caitong International Asset Management's SBFM Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Sunshine Biopharma (SBFM) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #2833 among its holdings.

9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

  • Caitong International Asset Management held 1 share of Sunshine Biopharma worth $2 as of Q2 2026.
  • Sunshine Biopharma was a new Caitong International Asset Management position in Q2 2026.
  • Sunshine Biopharma made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2833 holding.
  • 9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.